Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending June 26, 2012. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares, authorized by shareholders at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 1,200,000 ordinary shares of 25 pence each.
- Transaction Date: June 26, 2012.
- Price Range: Highest price paid was 1,484.5 pence per share; lowest price paid was 1,472.5 pence per share.
Material Changes and Treasury Holdings
Following the June 26 transaction, the company's treasury share holdings were updated as follows:
- Settled Treasury Shares: 472,107,927 shares, representing 8.64% of total issued share capital.
- Total Treasury Shares (including unsettled): 475,557,927 shares, representing 9.52% of current total voting rights.
- Shares in Issue (excluding treasury): 4,994,939,438 shares.
The filing notes that the number of shares in issue represents the total voting rights and serves as the denominator for shareholder notification calculations under the Financial Services Authority's Disclosure and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase or subscribe for securities in any jurisdiction.
Key Facts for Investor Verification
- Verify the total cost of the 1,200,000 share repurchase based on the disclosed price range (1,472.5 to 1,484.5 pence).
- Confirm the updated total voting rights denominator (4,994,939,438 shares) for compliance with disclosure thresholds.
- Note that the company intends to hold the repurchased shares in Treasury rather than retiring them immediately.
- Recognize that this filing does not contain operational or financial performance data for the period.